Attention-deficit/hyperactivity disorder (ADHD) is not limited to the symptoms of inattention and hyperactivity. Learn about ...

As awareness of ADHD among adults increases, diagnosed individuals need greater understanding and support from those around ...

Life expectancy rates among people with ADHD may be significantly lower, a new study has found. But access to care and ...

While ADHD can affect someone's behavior, healthy romantic relationships can happen too.

A new study linked ADHD to a reduced life expectancy. Experts explain the risks, how ADHD impacts long-term health, and what ...

Time blindness is a cognitive condition that affects an individual's ability to perceive and manage time, often linked to ADHD. Those with the conditi ...

ADHD evaluation costs vary widely depending on factors like insurance, location and clinic options, with sliding-scale fees ...

ADHD’s rising prevalence has been met with some dismissiveness. As I wrote in 2023, questions have been raised about the ...

McCarthy S, Wilton L, Murray M, et al (2012). The epidemiology of pharmacological treatments for attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

Adults with diagnosed attention-deficit/hyperactivity disorder (ADHD) have a shorter life expectancy than those without.

Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.